NCT00001765View on ClinicalTrials.gov

Stem Cell Transplant Following Low-Intensity Chemotherapy to Treat Chronic Granulomatous Disease

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 30, 1998

Study Completion Date

February 28, 2005

Conditions
Chronic Granulomatous Disease
Interventions
DEVICE

Nexell Isolex with T-cell Depletion

DEVICE

Baxter isolex 300i

Trial Locations (1)

20892

National Institute of Allergy and Infectious Diseases (NIAID), Bethesda

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00001765 - Stem Cell Transplant Following Low-Intensity Chemotherapy to Treat Chronic Granulomatous Disease | Biotech Hunter | Biotech Hunter